Market Research Logo

Assisted Reproductive Technology (ART) Market Size, Share & Trends Analysis Report By Type (IVF, AI-IUI, FER, Others), By End Use (Hospitals, Fertility Clinics), By Procedures And Segment Forecasts, 2018 - 2025

Assisted Reproductive Technology (ART) Market Size, Share & Trends Analysis Report By Type (IVF, AI-IUI, FER, Others), By End Use (Hospitals, Fertility Clinics), By Procedures And Segment Forecasts, 2018 - 2025

The global assisted reproductive technology (ART) market is expected to reach USD 45 billion by 2025, according to a new report by Grand View Research, Inc. Childbearing postponement is one of the high impact rendering drivers of the infertility treatment market. The reproductive behavior and pattern of some of the nations such as few European nations have shifted from early to late childbearing pattern.

Increasing marital age, rising tobacco and alcohol consumption, increasing obesity rate are some of the other factors contributing to the market growth. Furthermore, increasing incidence rate of conditions such as poly-cystic ovarian syndrome (PCOS), tubal factors and endometriosis are other drivers of the market.

According to the Society for Assisted Reproductive Technology, 2012 was the year with highest percentage of babies born through IVF treatment. The treatment has become more successful and has gained more acceptance, which is further expected to increase the market size in the coming years.

Further Key Findings from the Report Suggest:

  • Fresh non-donor was the largest ART market procedure segment in 2014. The fact that fresh eggs and sperms increase the number of successful pregnancies is expected to drive segment growth over the forecast period.
  • According to a recent study published in the New England Journal of Medicine.by the researchers from Vietnam and China, frozen embryos are not more effective in comparison to the fresh embryos for all women, specifically those suffering from PCOS.
  • Frozen non-donor is identified as the most lucrative procedure segment of the assisted reproductive technology industry. A new study claims that the fertility treatment with frozen embryos may have more probability of success than those performed with fresh embryos.
  • IVF with ICSI dominated the technology type market segment owing to increase in the chances of successful fertilization, and exceptional technique for treating male infertility. As per the study published in fertility journal Human Reproduction Update 2017, North America, Europe, New Zealand and Australia, men’s sperm counts declined by 50-60% over the period between 1973 and 2011. Changing lifestyle and environmental factors are some of the factors responsible for the decline of sperm counts.
  • Frozen embryo replacement (FER) is anticipated to grow at a rapid rate over the forecast period owing to the fact that in the clinics fresh embryos are used first and only good quality and spare embryos are transferred at a later stage. The trend is to transfer single embryos rather than risking by transferring two or more embryos. This is expected to increase the FER segment market in the coming years.
  • Europe dominated the market and is anticipated to maintain its dominance during the forecast period The Asia Pacific region is likely to witness significant growth over the next decade due to improving healthcare infrastructure, increasing awareness and adoption of IVF procedures.
  • Technological advancements is expected to drive the market in the coming years. In 2016, INVO Bioscience, Inc. announced the FDA approval of first intravaginal culture system, INVOcell, wherein women’s vagina is used as a natural incubator and the clinical trials have produced pregnancy similar to traditional IVF treatments
  • Some of the key players are California Cryobank, Bloom IVF Centre, Parallabs, OvaScience, Anecova, Origio, Microm Ltd., Merck KGaA, Ferring Pharmaceuticals, Boston Science Corporation and Hamilton Throne Ltd.


Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Data Analysis
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Constant rise in infertility rate
3.1.1.2 Growing awareness and social acceptance of assisted reproductive technologies
3.1.1.3 Increasing number of single women and same-sex couples
3.1.2 Market restraints analysis
3.1.2.1 Changing government regulations
3.2 Penetration & Growth Prospect Mapping
3.3 Assisted Reproductive Technology - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.4 Assisted Reproductive Technology - Industry Analysis - Porter’s
Chapter 4 Assisted Reproductive Technology (ART) Market: Procedure Estimates & Trend Analysis
4.1 Assisted Reproductive Technology (ART): Procedure Analysis
4.2 Fresh Donor
4.2.1 Fresh donor market, 2014 - 2025 (USD Million)
4.3 Fresh Nondonor
4.3.1 Fresh nondonor market, 2014 - 2025 (USD Million)
4.4 Frozen Donor
4.4.1 Frozen donor market, 2014 - 2025 (USD Million)
4.5 Frozen Nondonor
4.5.1 Frozen nondonor market, 2014 - 2025 (USD Million)
4.6 Embryo/Egg Banking
4.6.1 Embryo/egg banking market, 2014 - 2025 (USD Million)
Chapter 5 Assisted Reproductive Technology (ART) Market: Type Estimates & Trend Analysis
5.1 Assisted Reproductive Technology (ART): Type Analysis
5.2 IVF
5.2.1 IVF market, 2014 - 2025 (USD Million)
5.2.1.1 IVF with ICSI
5.2.1.2 IVF without ICSI
5.3 AI-IUI
5.3.1 AI-IUI market, 2014 - 2025 (USD Million)
5.4 FER
4.4.1 FER market, 2014 - 2025 (USD Million)
5.5 Others
5.5.1 Others market, 2014 - 2025 (USD Million)
Chapter 6 Assisted Reproductive Technology (ART) Market: End-use Estimates & Trend Analysis
6.1 Assisted Reproductive Technology (ART): End-use Analysis
6.2 Hospital
6.2.1 Hospital market, 2014 - 2025 (USD Million)
6.3 Fertility Clinics
6.3.1 Fertility clinics market, 2014 - 2025 (USD Million)
Chapter 7 Assisted Reproductive Technology (ART) Market: Regional Estimates & Trend Analysis
7.1 Assisted Reproductive Technology (ART) Market: Regional Movement analysis
7.2 North America
7.2.1 North America Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.3.2 UK
7.3.2.1 UK Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.3.4 France
7.3.4.1 France Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.4.2 Japan
7.4.2.1 Japan Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.4.3 China
7.4.3.1 China Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.4.4 India
7.4.4.1 India Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.6 Middle East and Africa (MEA)
7.6.1 Middle East and Africa Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Company Profiles
8.2.1 Cosmos Biomedical
8.2.1.1 Company Overview
8.2.1.2. Financial Performance
8.2.1.3 Product Benchmarking
8.2.1.4 Strategic Initiatives
8.2.2 Microm UK Ltd.
8.2.2.1 Company Overview
8.2.2.2. Financial Performance
8.2.2.3 Product Benchmarking
8.2.2.4 Strategic Initiatives
8.2.3 Origio
8.2.3.1 Company Overview
8.2.3.2. Financial Performance
8.2.3.3 Product Benchmarking
8.2.3.4 Strategic Initiatives
8.2.4 IrvineScientific
8.2.4.1 Company Overview
8.2.4.2. Financial Performance
8.2.4.3 Product Benchmarking
8.2.4.4 Strategic Initiatives
8.2.5 Cryolab Ltd.
8.2.5.1 Company Overview
8.2.5.2. Financial Performance
8.2.5.3 Product Benchmarking
8.2.5.4 Strategic Initiatives
8.2.6 Parallabs
8.2.6.1 Company Overview
8.2.6.2. Financial Performance
8.2.6.3 Product Benchmarking
8.2.6.4 Strategic Initiatives
8.2.7 European Sperm Bank
8.2.7.1 Company Overview
8.2.7.2. Financial Performance
8.2.7.3 Product Benchmarking
8.2.7.4 Strategic Initiatives
8.2.8 Bloom IVF Centre
8.2.8.1 Company Overview
8.2.8.2. Financial Performance
8.2.8.3 Product Benchmarking
8.2.8.4 Strategic Initiatives
8.2.9 Ovascience
8.2.9.1 Company Overview
8.2.9.2. Financial Performance
8.2.9.3 Product Benchmarking
8.2.9.4 Strategic Initiatives
8.2.10 Ferring Pharmaceuticals
8.2.10.1 Company Overview
8.2.10.2. Financial Performance
8.2.10.3 Product Benchmarking
8.2.10.4 Strategic Initiatives
List of Tables
TABLE 1 Occurrence of infertility among couples
TABLE 2 Fertility affecting factors
TABLE 3 IUI success rate
TABLE 4 North America Assisted Reproductive Technology (ART) market, by country, 2014 - 2025 (USD Million)
TABLE 5 North America Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 6 North America Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 7 North America Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 8 U.S. Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 9 U.S. Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 10 U.S. Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 11 Canada Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 12 Canada Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 13 Canada Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 14 Europe Assisted Reproductive Technology (ART) market, by country, 2014 - 2025 (USD Million)
TABLE 15 Europe Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 16 Europe Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 17 Europe Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 18 UK Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 19 UK Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 20 UK Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 21 France Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 22 France Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 23 France Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 24 Germany Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 25 Germany Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 26 Germany Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 27 Asia Pacific Assisted Reproductive Technology (ART) market, by country, 2014 - 2025 (USD Million)
TABLE 28 Asia Pacific Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 29 Asia Pacific Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 30 Asia Pacific Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 31 India Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 32 India Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 33 India Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 34 China Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 35 China Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 36 China Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 37 Japan Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 38 Japan Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 39 Japan Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 40 Latin America Assisted Reproductive Technology (ART) market, by country, 2014 - 2025 (USD Million)
TABLE 41 Latin America Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 42 Latin America Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 43 Latin America Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 44 Brazil Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 45 Brazil Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 46 Brazil Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 47 Mexico Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 48 Mexico Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 49 Mexico Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 50 MEA Assisted Reproductive Technology (ART) market, by country, 2014 - 2025 (USD Million)
TABLE 51 MEA Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 52 MEA Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 53 MEA Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
TABLE 54 South Africa Assisted Reproductive Technology (ART) market, by procedure, 2014 - 2025 (USD Million)
TABLE 55 South Africa Assisted Reproductive Technology (ART) market, by technology, 2014 - 2025 (USD Million)
TABLE 56 South Africa Assisted Reproductive Technology (ART) market, by end use, 2014 - 2025 (USD Million)
List of Figures
FIG. 1 Market summary 2016, (USD Million)
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraints relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping, 2016
FIG. 13 SWOT analysis, by factor (political & legal, economic, and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Assisted Reproductive Technology (ART) market, technology outlook: Key takeaways
FIG. 16 Assisted Reproductive Technology (ART): Technology movement analysis
FIG. 17 IVF market, 2014 - 2025 (USD Million)
FIG. 18 AI-IUI market, 2014 - 2025 (USD Million)
FIG. 19 FER market, 2014 - 2025 (USD Million)
FIG. 20 Others market, 2014 - 2025 (USD Million)
FIG. 21 Assisted Reproductive Technology (ART) market, procedure outlook: Key takeaways
FIG. 22 Assisted Reproductive Technology (ART): Procedure movement analysis
FIG. 23 Fresh donor market, 2014 - 2025 (USD Million)
FIG. 24 Fresh nondonor market, 2014 - 2025 (USD Million)
FIG. 25 Frozen donor market, 2014 - 2025 (USD Million)
FIG. 26 Frozen nondonor market, 2014 - 2025 (USD Million)
FIG. 27 Embryo/egg banking market, 2014 - 2025 (USD Million)
FIG. 28 Assisted Reproductive Technology (ART) market, end use outlook: Key takeaways
FIG. 29 Assisted Reproductive Technology (ART): End use movement analysis
FIG. 30 Hospitals market, 2014 - 2025 (USD Million)
FIG. 31 Fertility clinics market, 2014 - 2025 (USD Million)
FIG. 32 Regional market place: Key takeaways
FIG. 33 Assisted Reproductive Technology (ART) market: Regional movement analysis
FIG. 34 North America Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 35 U.S. Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 36 Canada Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 37 Europe Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 38 UK Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 39 Germany Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 40 France Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 41 Asia Pacific Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 42 Japan Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 43 China Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 44 India Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 45 Latin Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 46 Brazil Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 47 Mexico Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 48 Middle East and Africa Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 49 South Africa Assisted Reproductive Technology (ART) market, 2014 - 2025 (USD Million)
FIG. 50 Strategy framework

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report